ʻAʻole hiki ke hoʻomalu mau i ka mālama ʻana i ke ʻano o ka maʻi mellitus type 2 me ke kōkua o ka haʻalulu haʻahaʻa-a me ke kaumaha o nā ʻiʻo. A he pono e hakakā i ka hyperglycemia, no ka mea, ʻo ka pili maʻi lapaʻau e alakaʻi ai i nā hoʻopiʻi koʻikoʻi.
I waena o nā mea paʻakikī e pili ana i nā pilikia cardiovascular. ʻO ka maʻi Diabetalong (Latin Diabetalong), kahi lāʻau lapaʻau hypoglycemic me kahi hoʻokuʻu lōʻihi a hoʻololi paha, e kōkua i ka hōʻemi o ka hoʻouluʻana i ka CVD.
Hiki i nā pono Pharmacological
ʻO nā waiwai antidiabetic o ka lāʻau lapaʻau ma muli o nā mea hoʻohui gliclazide. Aia i nā papa he 30 a 60 mg o ka mea waiwai a me nā mea waiwai: calcium stearate, hypromellose, talc, lactose monxidate, colloidal silicon dioxide.
ʻO ka maʻi Diabetalong kahi lāʻau lapaʻau o ka papa o ka makahiki o ka sulfonylurea. Ke komo nei ia i ka kahe koko, e hoʻoulu ai ka gliclazide i ka hōʻailona o ka hormone endogenous e nā β-cells o ka pancreas, hoʻihoʻi i ka hoʻohana ʻana i nā glucose (e hoʻolōʻihi i ka hana o ka glycogen synthase). I loko o kekahi mau lā mai ka hoʻomaka ʻana o ke papa, ʻano maʻamau ka ʻike glycemic. ʻO ka manawa manawa mai ka mālama ʻana i ka meaʻai ma ka digestive tract a hiki i ka hoʻoneʻe ʻana o ka insulin endogenous ua hoʻemi ʻia, a ke hōʻemi nei nā hōʻailona glycemic e ka meaʻai.
He mea kupaianaha ia i mau makahiki 2 ma hope o ka lawe ʻana i ka lāʻau lapaʻau, mālama ʻia ke ʻano o ka insulin postprandial a me C-peptide. ʻO ka hopena ma ke kino ke Diabetalong he paʻakikī:
- Kāohi i ka hoʻoliʻoli momona;
- Loaʻa ia ia kahi hopena antioxidant hopena;
- Hoʻāla ka mea huna insulin;
- Loaʻa ia he hopena hemovascular (hoʻopaʻa i ka pākuʻi platelet).
Ke komo ka glucose i ke kahe, hiki i ka gliclazide ke hoonui nei i ka hana o ka insulin. Me ka mālama mau ʻana, luhi nei ka lāʻau lapaʻau:
Nā maʻi hoʻopiʻi Microvascular - retinopathy (kahi hana hoʻopihapiha ma ka retina) a me nā nephropathy (kahi hana renal);- Nā hopena Macrovascular - nā hōʻeha, ka puʻuwai o ka naʻau.
Nā maʻi hoʻopiʻi Microvascular - retinopathy (kahi hana hoʻopihapiha ma ka retina) a me nā nephropathy (kahi hana renal);Nā hiʻohiʻona Pharmacokinetic
Mai ka ʻōpū, hoʻohuihui ka lāʻau i ka piha. Loaʻa ka ʻike kiko loa ma ka kahe koko ma hope o 2-6 mau hola, a no nā papa me MV - 6-12 mau hola.
Hoʻomaʻa ka hopena therapeutic i nā hola 24, a paʻa nā protein glycazide i 85-99%. I loko o ka puuwai, ua hoʻohuli ʻia kahi huaolaola i loko o nā metabolites, ʻo kekahi o lākou ka hopena maikaʻi i ka microcirculation. ʻO ka hapa hapalua he 8-12 mau hola, no nā papa me MB - 12-16 mau hola. Hoʻokuʻu ʻia ka lāʻau lapaʻau e 65% me ka mimi, ma ka 12% me nā feces.
ʻO wai ka mea i hōʻike ʻia i ka lāʻau lapaʻau
ʻO ke kumu no ke koho ʻana i ka maʻi Diabetalong ko nā maʻi like ʻole 2, ʻo ia hoʻi e like me ka monotherapy a me ka hoʻohui pū i ka insulin a i ʻole nā mea like antidiabetic e like.
Nā maʻi a me nā palena
- ʻAno maʻi type 1;
- Hoʻoikaika pū kekahi;
- Hoʻoiho o ka ate;
- Pilikia hooikaika;
- Ketoacidosis;
- Hypo- a me hyperthyroidism;
- Diabetic a hyperosmolar coma;
- ʻŌpū a me ka umauma
- ʻO nā hōʻeha koʻikoʻi a me ke ahi.
Hoʻopili ke maʻi Diabetalong i nā wahine hāpai, inā ʻaʻole hiki ke ʻoki ʻia a ʻo ka hoʻoulu ʻana i ka maʻi, ua hoʻohuli ʻia ke keiki me nā mea kūlohelohe.
ʻAʻole ʻae ʻia ka hoʻohana ʻana o ka glycoside i ka wā i lawe pinepine ʻia me ka miconazole.
Nā hopena hopena
Hiki i nā hopena ke kū ʻole no ka gastrointestinal tract e hiki ai ke ʻeha o ka dyspeptic i ke ʻano o ka hoʻouka ʻana o ka maʻi pākaʻi, luaʻi, ka ʻōpū o ka ʻōpū. Mai ka ʻaoʻao o ka metabolism, hiki i ka hypoglycemia, no ka ʻōnaehana kao - eosinophilia, cytopenia, anemia. Ma ka ʻāpana o ka ʻili, hiki i nā allergy a me nā photosensitization. Mai nā naʻau sensory aia nā makaʻu hūʻole, nā hōʻeha, ka nalowale o ka hoʻonohonoho ʻana, nalowale o ka ikaika.
Hoʻopili i nā lāʻau lapaʻau
Hoʻonui ʻia ka maikaʻi o ka glycoside me ka hoʻohana pū ʻana me ka anabolic steroid, ACE inhibitors, β-blockers, cimetidine, fluoxetine, salicylates, MAO inhibitors, Flucanazole, Pentoxifylline, Miconazole, Theophylline, Tetracycline.
ʻAi nāwaliwali o ka glycoside i ka wā i hoʻohana pinepine ʻia me ka barbiturates, glucocorticoids, sympathomimetics, saluretics, rifampicin, nā kīnā mana hoʻomalu, estrogens.
Pehea e hoʻopili ai
Pono ke lawe ʻia ʻo Glycloside me ka ʻaina o ka meaʻai. Unuhi ʻia ka papa ʻaʻa, holoi ʻia me ka wai ma ka mahana o ka lumi. Koho ka endocrinologist i nā helu a me ka mālama ʻana i ka mālama ʻana i nā maʻi āpau, e noʻonoʻo ana i ke ʻano o ka maʻi a me ke ʻano o ka maʻi maʻi o ka maʻi maʻi. No ka lāʻau lapaʻau ʻo Diabetalong, nā ʻōlelo aʻoaʻo no ka hoʻohana ʻana i kahi hana hoʻomaka o 30 mg a me kahi hoʻoponopono hou aʻe ma ke ala o ka hoʻonui (inā pono).
No ka hoʻokō ʻana i ka hopena therapeutic kiʻekiʻe, pono e hahai i nā kānāwai maʻalahi.
- Hoʻoiho ʻia ka hopena holoʻokoʻa o kēlā me kēia lā, maikaʻi loa - i ke kakahiaka;
- Hiki ke hoʻoponopono ʻia ka nui o ka lāʻau i loko o 30 -120 mg / lā;
- Inā hemo ʻole ka manawa hoʻokomo ʻia, ʻaʻole e pālua ʻia ka pākeke i ka manawa kūpono e hiki mai ai;
- Ke helu nei i ka pauʻa, lawe ke kauka i nā heluhelu i ka mika a me ka HbAlc.
Me ka loaʻa ʻole o ka hana kūpono, hoʻonui ʻia ke ʻano (ma hope o ke kuʻikahi me ke kauka), akā ʻaʻole ia ma mua o hoʻokahi mahina ma hope o ka hopu mua ʻana o ka glycoside. I kēlā me kēia mau pule 2, me ka uku piha o ka glycemia, hiki ke hoʻonui i ka nui.
He mea pono ke noʻonoʻo i kahi 1 papa o ka Diabetalong PV i loaʻa he 60 mg o ka glyclazide, ua pili kēia me 2 papa o ka Diabetalong MV 30 mg i kēlā
Ke hoʻoneʻe nei i kahi maʻi maʻi i gliclazide mai nā lāʻau lapaʻau hypoglycemic ʻē aʻe, ʻaʻole pono nā hoʻomaha, koe wale nō nā derivatives sulfonylurea. ʻO ka ʻōmua mua ma kēia hihia he maʻamau - 30 mg, inā ʻaʻole i kuhikuhi ka endocrinologist i kāna hana.
I ka hoʻomaʻamaʻa paʻakikī, hoʻohana ʻia ʻo Diabetalong me nā ʻano like ʻole o ka inikini, biagudins, inhibitor α-glucosidase. Me ka makaʻala, kuhikuhi ʻia ka lāʻau lapaʻau i ka poʻe maʻi maʻi mai ka hui a me ka hopena hypoglycemic (hōʻino i ka waiʻona, hana hoʻoikaika kino a ʻano haʻukiʻi paha, ka pōloli, ke koʻikoʻi koʻikoʻi). Hoʻopilikia ʻia nā hana Hematopoietic me ka hoʻomohala ʻana i ka anemia, thrombocytopenia, leukopenia, granulocytopenia.
ʻO nā mea mālama palekana
I mea e pale ai i ka hypoglycemia, mea koʻikoʻi ka manawa o ka hoʻohana ʻana i nā lāʻau lapaʻau no ka ʻai ʻana, e pale ai i nā wāwahi nui i ka meaʻai, me ka hoʻopau ʻana i ke komo ʻana i ka inu wai meaʻaiʻai. ʻO ka hoʻokō ʻana o ka β-blockers hiki ke hoʻokaʻawale i nā hōʻailona o ka hypoglycemia.
Hiki ke hoʻomaopopo i ke kaona hypoglycemic e ke poʻo, ka hui koikoi, hoʻomāhewa ʻole ʻia i ka pōloli, ke kaumaha, nāwaliwali, a me ka pupule blurred, nā maʻi dyspeptic. Hōʻike pū ʻia nā hopena adenergic: hopohopo, ʻeuhe, hoʻokahe i ke kahe o ke koko, maʻi ʻōpio coronary, ʻeha haunaele puʻuwai. ʻO nā maʻi Dyspeptic, nā haunaele i ka luhi o ka defecation, a me nā hopena kino (rashes, discomfort, erythema, urticaria, Quincke's edema) he ʻano.
ʻAʻole hiki ke hoʻokō maikaʻi ʻia me ka ʻole o kaʻai haʻahaʻa-haʻahaʻa. Ma muli o ka loaʻa ʻana o ka hopena maikaʻi loa, pono e lawe ka poʻe lawe i ka lāʻau lapaʻau me ka mālama. Hoʻololi nā ʻōnaehana like i nā ʻelele o nā ʻoihana e pili ana i ka kiʻekiʻe o ka hopena kiʻekiʻe a me ka ulu ʻana.
Hoʻomoe ka naʻau o nā palaleka o nā aʻi a me nā papa hana i ka hepatitis, he hoʻonui i ka hana enima.
Inā ʻike ka mea ʻai, pono ia e ʻai i nā kīʻaha, inu i ke kīʻaha kīʻaha a i ʻole kekahi mea kiʻekiʻe i nā waihona. Ma hope o ka holomua o ke ʻano, pono ka endocrinologist e kūkākūkā me ka hoʻoponopono ʻana i ka hopena a i ʻole ke hoʻololi i ka lāʻau lapaʻau.
Nā hiʻohiʻona o ka lāʻau
Wahi a ka māhele ikaika no Diabetalong, ʻo ka analoge ka mea e lilo ai ka Glidiab i hōʻea a hiki i ka 140 rubles. Hāʻawi nā kauka i nā lāʻau Diabeton a me Diabeton MV i kahi kiʻekiʻe kiʻekiʻe i nā kumukūʻai ma waena o 286 a 318 rubles. I nā mākaukau synonymic, hiki ke ʻōlelo pū ʻia ʻo Glyclada.
ʻO ka hoʻomākaukau me ka hopena hypoglycemic like like me Amaril, Glimepiride, Glemaz, Glyurenorm e maikaʻi loa i ka hoʻopili. Ua kuhikuhi ʻia lākou no hypersensitivity a i ʻole nā contraindications no ka glycoside.
E hoʻokuʻu i ke ʻano, nā kūlana mālama
Hoʻokomo ʻia nā papa maʻi Diabetalong i huaʻai ʻia e Synthesis OJSC a me MS-Vita LLC i nā pā kuhi. Hoʻokomo ʻia nā mālama i kahi pahu kāleka.
Hiki ke mālama ʻia ka lāʻau lapaʻau no 3 mau makahiki ma ka mahana o ka lumi, i waho o ka hiki o ke aniani a me nā keiki. I loko o nā lāʻau lapaʻau, loaʻa ke Diabetalong no ka lapaʻau ʻana ma ke kumukūʻai o 98-127 rubles. no nā papa 60 o 30 mg.
Hōʻike Diabetalong
Ma ka maʻi Diabetolong i loaʻa i nā hopena o ka Diabetolong, ma nā loiloi e hoʻomaopopo i kona pono.
- Hoʻonui ka hoʻomaikaʻi ʻana i nā hōʻailona o ka glucometer;
- A kūpono kūpono me nā lāʻau lapaʻau ʻē aʻe;
- He kumukūʻai kūpono loa o nā lāʻau lapaʻau;
- ʻO ka hiki ke hoʻolilo i ka momona i ka wā mālama.
ʻAʻole mākona nā kānaka āpau i ka pono o ka mālama mau (a hiki i 5 mau manawa i ka lā) ka mana o ka glycemic, akā i ka manawa e kūpaʻa ana kāna mau kuhikuhi a ua emi nā pono no ka mālama pono ʻana.
Ma keʻano holoʻokoʻa, ʻo ka maʻi Diabetalong kahi hilinaʻi antidiabetic hilinaʻi i hoʻomaʻemaʻe maikaʻi i ka kiʻi o ka glycemic. Ke hoʻohana pono ʻia, hiki iā ia ke pale i nā hanana cardiovascular a me nā pilikia koʻikoʻi o ka maʻi maʻamau ʻo ka maʻi 2.
